
EU Pharmaceutical Reform Aims to Strengthen Supply Chains and Ensure Equal Access to Medicines
Prime Highlight: The EU is reforming its pharmaceutical laws to make medicines more accessible, affordable, and secure while supporting innovation

Prime Highlight: The EU is reforming its pharmaceutical laws to make medicines more accessible, affordable, and secure while supporting innovation

Prime Highlights: Eli Lilly will invest €2.6 billion to build a new manufacturing plant in Katwijk, the Netherlands, to expand

Prime Highlights The UK Health Security Agency (UKHSA) has urged gay, bisexual, and other men who have sex with men

Prime Highlights: Germany’s growing reliance on China and India for medicines is raising concerns about Europe’s medical security and independence.

Prime Highlights: The Sickle Cell Transitions Policy Lab calls for EU and national leaders to implement policies that help young

Prime Highlights: The European Parliament’s Renew Europe group is urging the EU to take stronger action against the harmful effects

Prime Highlights Health industry groups are urging the European Commission to simplify the Medical Device Regulation (MDR) and In Vitro

Prime Highlight: Whooping cough (pertussis) is rapidly resurging across Europe, with infants under two months, too young to be vaccinated,

Prime Highlights: The European Union approved Kisunla, an Alzheimer’s drug by Eli Lilly, for treating mild cognitive impairment and early-stage

Prime Highlights: A new twice-yearly HIV prevention injection, lenacapavir, will be available at low cost in 120 lower-income countries starting
Euro Health Leaders stands out as the premier destination for anyone seeking a comprehensive and insightful view of the dynamic healthcare landscape in Europe.